- Home
- GRFS vs VRNS Comparison
GRFS vs VRNS Comparison
Compare GRFS & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- VRNS
- Stock Information
- Founded
- GRFS 1940
- VRNS 2004
- Country
- GRFS Spain
- VRNS United States
- Employees
- GRFS N/A
- VRNS N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- VRNS Computer Software: Prepackaged Software
- Sector
- GRFS Health Care
- VRNS Technology
- Exchange
- GRFS Nasdaq
- VRNS Nasdaq
- Market Cap
- GRFS 6.6B
- VRNS 6.8B
- IPO Year
- GRFS 2006
- VRNS 2014
- Fundamental
- Price
- GRFS $9.11
- VRNS $35.39
- Analyst Decision
- GRFS Hold
- VRNS Strong Buy
- Analyst Count
- GRFS 1
- VRNS 19
- Target Price
- GRFS $10.30
- VRNS $60.68
- AVG Volume (30 Days)
- GRFS 592.2K
- VRNS 3.5M
- Earning Date
- GRFS 01-01-0001
- VRNS 10-28-2025
- Dividend Yield
- GRFS 1.58%
- VRNS N/A
- EPS Growth
- GRFS 132.60
- VRNS N/A
- EPS
- GRFS 0.53
- VRNS N/A
- Revenue
- GRFS $8,744,226,659.00
- VRNS $608,677,000.00
- Revenue This Year
- GRFS $5.46
- VRNS $14.75
- Revenue Next Year
- GRFS $6.69
- VRNS $16.12
- P/E Ratio
- GRFS $22.60
- VRNS N/A
- Revenue Growth
- GRFS 9.32
- VRNS 11.37
- 52 Week Low
- GRFS $6.19
- VRNS $32.02
- 52 Week High
- GRFS $11.14
- VRNS $63.90
- Technical
- Relative Strength Index (RSI)
- GRFS 36.85
- VRNS 22.78
- Support Level
- GRFS $9.14
- VRNS $32.02
- Resistance Level
- GRFS $9.50
- VRNS $36.47
- Average True Range (ATR)
- GRFS 0.29
- VRNS 2.28
- MACD
- GRFS -0.02
- VRNS -3.21
- Stochastic Oscillator
- GRFS 26.39
- VRNS 10.60
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.